Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329453 · ClinicalTrials.gov registry record
Intestinal Immunity in Neurologic Disease
A clinical trial of Multiple Sclerosis and Parkinson Disease, sponsored by Yale University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06329453 is a study of Multiple Sclerosis and Parkinson Disease that is actively recruiting participants, run by Yale University. The registered enrollment target is 100 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06329453, a study of Multiple Sclerosis and Parkinson Disease, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to ascertain the functional profiles of the immune cells within the gastrointestinal tract and to determine how these cells contribute to autoimmune and neurologic diseases.
Conditions Studied
Interventions
- PROCEDURE Colon Tissue Biopsy
Study Locations (1)
Connecticut
- Yale MS Clinic - North Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-08-02 |
| Est. Completion | 2027-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06329453
The ClinicalTrials.gov registry entry for NCT06329453 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Colon Tissue Biopsy is the first listed.
NCT06329453 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06329453 about?
NCT06329453 is a clinical study titled "Intestinal Immunity in Neurologic Disease". The purpose of this study is to ascertain the functional profiles of the immune cells within the gastrointestinal tract and to determine how these cells contribute to autoimmune and neurologic diseases.
What is the current status of trial NCT06329453?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-08-02. Estimated completion is 2027-08-31.
What conditions does trial NCT06329453 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Parkinson Disease, REM Sleep Behavior Disorder.
What interventions are being tested in trial NCT06329453?
The interventions under investigation include: Colon Tissue Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT06329453?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06329453 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.